Pharma Marketing Network

This article summarizes a presentation by Thomas Willard, Vice President of Marketing at Schwartz Pharma, Inc., made at the CBI Forum on Pharmaceutical Branding held August 14-15, 2003, in Princeton, New Jersey. Willard discussed the difference between 'product' and 'brand' and identified the personnel beyond the marketing team that should be encouraged to buy-in to brand thinking.

This article is a review of a presentation by Keli Bennett, Consumer Marketing Director at Abbott Laboratories, made at the CBI Forum on Pharmaceutical Branding held August 14-15, 2003, in Princeton, New Jersey. Bennett contrasts and compares DR marketing and traditional DTC strategies and presents a Case Study showing the ROI benefit of integrating the two approaches.

This article summarizes results from Manhattan Research's recently released survey: ePharma Physician v3.0: The Future of Pharmaceutical eMarketing, which focused on the adoption of emerging technologies by an early adopter physician audience. This audience is not small and cannot be ignored! Data are presented showing which online marketing programs are considered most effective by this group of physicians and what they desire as the optimal channel mix for marketing programs.

CBI's Forum on Pharmaceutical Branding, August 14-15, 2003, in Princeton, NJ brings together marketing, product, brand and business development leaders to share their experiences and insights into how you can best position your brand in the market place.

Pharmaceutical Education Associates presents Understanding the OIG's Compliance Program Guidance for Pharmaceutical Manufacturers conference.

This article reviews a presentation made by David Ormesher, CEO of closerlook, inc. at the recent CBI eDetailing Conference in which he said, The future of eDetailing is physician relationship management. The benefits of creating long-term relationships include brand loyalty, detailed customer intelligence and sales integration with the field force.

In this presentation Sue Ramspacher, Senior Vice President, Portfolio Management, Market Measures/Cozint, summarized results of her firm's 2002 DTC Monitor study.

In this presentation Sue Ramspacher, Senior Vice President, Portfolio Management, Market Measures/Cozint, summarized results of her firm's 2002 DTC Monitor study.

This presentation put out-of-the-box marketing ideas such as Permission Marketing into the context of pharmaceutical promotions. Dr. Vanderveer -- the presenter -- posed important questions that pharmaceutical market researchers must ask themselves, especially in light of two looming pharmaceutical marketing crises: Decreasing ROI and Fewer Blockbuster Drugs.

This presentation put out-of-the-box marketing ideas such as Permission Marketing into the context of pharmaceutical promotions. Dr. Vanderveer -- the presenter -- posed important questions that pharmaceutical market researchers must ask themselves, especially in light of two looming pharmaceutical marketing crises: Decreasing ROI and Fewer Blockbuster Drugs.